Optic Neuritis Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by Delve
- Ankit Nigam
- Oct 28, 2020
- 4 min read
(Albany, US) DelveInsight has launched a new report on "Optic Neuritis - Market Insights, Epidemiology, and Market Forecast-2030".
DelveInsight's "Optic Neuritis - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Optic Neuritis, historical and forecasted epidemiology as well as the Optic Neuritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
· A rare condition with an estimated annual incidence of 6.4 per 100,000 cases in population in the United States.
· ON is most common among adults, age 20 to 40 years, and its symptoms generally improve in 80 percent of patients over few weeks.
· More females are affected than males and approximately five out of every one-hundred thousand people are affected by ON every year
Request for free sample report: https://www.delveinsight.com/sample-request/optic-neuritis-market
The report covers the descriptive overview of Optic Neuritis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
Comprehensive insight has been provided into the Optic Neuritis epidemiology and treatment in the 7MM
Additionally, an all-inclusive account of both the current and emerging therapies for Optic Neuritis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
A detailed review of Optic Neuritis market; historical and forecasted is included in the report, covering drug outreach in the 7MM
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Optic Neuritis market
Optic Neuritis (ON) is the swelling of the eye’s optic nerve. The optic nerve carries light signals from the back of the eye to the brain so that a person can see. A person cannot see clearly if the optic nerve is swollen, damaged or is infected.
It is an acute rare disorder which usually occurs in one eye, and is being characterized by the symptoms including blurring of vision, a loss of part or all of central vision, reduced color vision, and dimness of vision.
Most patients with ON have eye pain which characteristically worsen with movement of the eye.
Request for free sample report: https://www.delveinsight.com/sample-request/optic-neuritis-market
· Biogen
· Mitochon Pharmaceuticals
· Noveome Biotherapeutics
· And Many Others
· Opicinumab
· MP101
· ST266
· And Many Others
Request for free sample report: https://www.delveinsight.com/sample-request/optic-neuritis-market
1. Key Insights
2. Executive Summary of Optic Neuritis
3. Competitive Intelligence Analysis for Optic Neuritis
4. Optic Neuritis: Market Overview at a Glance
4.1. Optic Neuritis Total Market Share (%) Distribution in 2017
4.2. Optic Neuritis Total Market Share (%) Distribution in 2030
5. Optic Neuritis: Disease Background and Overview
5.1. Introduction
5.2. Sign and Symptoms
5.3. Pathophysiology
5.4. Risk Factors
5.5. Diagnosis
6. Patient Journey
7. Optic Neuritis Epidemiology and Patient Population
7.1. Epidemiology Key Findings
7.2. Assumptions and Rationale: 7MM
7.3. Epidemiology Scenario: 7MM
7.3.1. Optic Neuritis Epidemiology Scenario in the 7MM (2017-2030)
7.4. United States Epidemiology
7.4.1. Optic Neuritis Epidemiology Scenario in the United States (2017-2030)
7.5. EU-5 Country-wise Epidemiology
7.5.1. Germany Epidemiology
7.5.1.1. Optic Neuritis Epidemiology Scenario in Germany (2017-2030)
7.5.2. France Epidemiology
7.5.2.1. Optic Neuritis Epidemiology Scenario in France (2017-2030)
7.5.3. Italy Epidemiology
7.5.3.1. Optic Neuritis Epidemiology Scenario in Italy (2017-2030)
7.5.4. Spain Epidemiology
7.5.4.1. Optic Neuritis Epidemiology Scenario in Spain (2017-2030)
7.5.5. United Kingdom Epidemiology
7.5.5.1. Optic Neuritis Epidemiology Scenario in the United Kingdom (2017-2030)
7.5.6. Japan Epidemiology
7.5.6.1. Optic Neuritis Epidemiology Scenario in Japan (2017-2030)
8. Treatment Algorithm, Current Treatment, and Medical Practices
8.1. Optic Neuritis Treatment and Management
8.2. Optic Neuritis Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of Optic Neuritis Treatment
11. Marketed Products
11.1. List of Marketed Products in the 7MM
11.2. Drug Name: Company Name
11.2.1. Product Description
11.2.2. Regulatory Milestones
11.2.3. Other Developmental Activities
11.2.4. Pivotal Clinical Trials
11.2.5. Summary of Pivotal Clinical Trial
List to be continued in report
12. Emerging Therapies
12.1. Key Cross
12.2. Drug Name: Company Name
12.2.1. Product Description
12.2.2. Other Developmental Activities
12.2.3. Clinical Development
12.2.4. Safety and Efficacy
12.2.5. Product Profile
List to be continued in report
13. Optic Neuritis: Seven Major Market Analysis
13.1. Key Findings
13.2. Optic Neuritis Market Size in 7MM
13.3. Optic Neuritis Market Size by Therapies in the 7MM
14. Attribute analysis
15. 7MM: Market Outlook
15.1. United States: Market Size
15.1.1. Optic Neuritis Total Market Size in the United States
15.1.2. Optic Neuritis Market Size by Therapies in the United States
15.2. EU-5 countries: Market Size and Outlook
15.3. Germany Market Size
15.3.1. Optic Neuritis Total Market Size in Germany
15.3.2. Optic Neuritis Market Size by Therapies in Germany
15.4. France Market Size
15.4.1. Optic Neuritis Total Market Size in France
15.4.2. Optic Neuritis Market Size by Therapies in France
15.5. Italy Market Size
15.5.1. Optic Neuritis Total Market Size in Italy
15.5.2. Optic Neuritis Market Size by Therapies in Italy
15.6. Spain Market Size
15.6.1. Optic Neuritis Total Market Size in Spain
15.6.2. Optic Neuritis Market Size by Therapies in Spain
15.7. United Kingdom Market Size
15.7.1. Optic Neuritis Total Market Size in the United Kingdom
15.7.2. Optic Neuritis Market Size by Therapies in the United Kingdom
15.8. Japan Market Outlook
15.8.1. Japan Market Size
15.8.2. Optic Neuritis Total Market Size in Japan
15.8.3. Optic Neuritis Market Size by Therapies in Japan
16. Access and Reimbursement Overview of Optic Neuritis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
20.1. Bibliography
20.2. Report Methodology
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Request for free sample report: https://www.delveinsight.com/sample-request/optic-neuritis-market
About DelveInsight
DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for
Browse through our vast repository from here.
Media Contact Company Name: DelveInsight Business Research LLP Contact Person: Ankit Nigam Email: info@delveinsight.com Phone: +19193216187 City: Albany State: New York Country: United States Website: https://www.delveinsight.com/
Comments